Bank of America remains optimistic about Nvidia, affirming its buy rating after discussions with the company's management at the Consumer Electronics Show. The firm emphasized Nvidia’s role as a leader in artificial intelligence (AI), describing its silicon, system, and software platform as pivotal in driving growth across AI applications like robotics, workstations, PCs, and autonomous vehicles.
Truist highlighted BioNTech as a strong player in oncology, even as its COVID-19 vaccine, Comirnaty, brought the company mainstream recognition. With the pandemic fading, Truist sees a shift in investor focus toward BioNTech’s oncology portfolio, which they termed an “oncology powerhouse.”
Citi initiated coverage of News Corp with a buy rating, setting a $36 price target. The firm cited strong positioning within the media sector as a key factor for its optimism.
Bernstein upgraded Thermo Fisher to outperform, expressing confidence in its ability to excel by 2025. While acknowledging some exposure to preclinical research, the firm pointed to Thermo Fisher’s revenue from later-stage research and production as a driver for potential outperformance.
After removing Ulta from its top picks in mid-2024, Oppenheimer reinstated the stock, viewing the current price as an attractive entry point.
Piper Sandler raised its rating on Nike to overweight, citing CEO Elliott Hill’s efforts to stabilize the marketplace and improve sentiment. While the call may be early, the firm sees recovery potential by fiscal 2026.
Citi upgraded McDonald’s to a buy, anticipating a turnaround in 2025. The firm expects McDonald’s to leverage its scale, regain market share, and improve margins after pricing challenges in recent years.
Citi also turned bullish on Sweetgreen, emphasizing the chain’s appeal beyond coastal regions. The firm sees pricing power and consumer demand bolstered by a scarcity of similar healthy dining options.
Mizuho identified Amazon, Alphabet, and DoorDash as its top picks for 2025, citing their strong market positions and potential for exceeding estimates.
MoffettNathanson downgraded Roku to sell, expressing concerns that market optimism over the company’s growth potential is overblown.
UBS upgraded Sunrun, noting that the solar company’s shares trade near historic lows despite improving fundamentals.
Barclays upgraded Snowflake after a year on the sidelines. The firm is now more optimistic about the company’s management and its response to AI-driven data demands.
Morgan Stanley raised its rating for Gilead Sciences, citing an increasingly compelling bull case. The price target jumped from $87 to $113.
Goldman Sachs Adjusts Ratings for AMD and NXP Semiconductor
Goldman Sachs downgraded AMD to neutral, citing rising competition, while upgrading NXP Semiconductor to buy. The firm sees significant upside for NXP but a more tempered outlook for AMD.
Wells Fargo raised its ratings for Bath & Body Works and Capri, noting valuation opportunities and positive growth trends.
Needham upgraded Lululemon, highlighting signs of demand recovery in late 2024. The firm set a price target of $475.
Bank of America reaffirmed its buy rating for Chevron, naming it a top idea for 2025. The firm pointed to rising free cash flow, cost-cutting measures, and clarity from recent acquisitions.
Deutsche Bank raised its price target on Tesla to $420, citing its ability to capitalize on AI applications for robotaxis and robotics.
While remaining bullish on Netflix, JPMorgan slightly reduced its price target to $1,000 due to foreign exchange challenges.
Monness Crespi Hardt upgraded Pinterest, citing improved profitability and an attractive valuation.
UBS upgraded several retailers, including Abercrombie & Fitch, Burlington, Boot Barn, and Gildan, highlighting their growth potential and undervalued stock prices.
As a leading independent research provider, TradeAlgo keeps you connected from anywhere.